Viewing Study NCT06326502


Ignite Creation Date: 2025-12-25 @ 3:37 AM
Ignite Modification Date: 2025-12-26 @ 2:21 AM
Study NCT ID: NCT06326502
Status: RECRUITING
Last Update Posted: 2024-03-27
First Post: 2024-03-17
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: A Safety and Efficacy Study of Multiple Tyrosine Kinase Inhibitor Drug (ETN101) in Advanced Hepatocellular Carcinoma
Sponsor: Etnova Therapeutics Corp.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module